TRIM: Reduce position 20-30% into 305-315 zone on follow-through; keep core position with stop at 269; require three confirmations before adding back: (1) confirmed close above 330 on volume above 12 million shares, (2) quarter of working capital stabilization with receivables growing in line with revenue, (3) forward EPS revision that stock absorbs without breaking support (either direction).

• Forward P/E of 26.2x is valid only if consensus EPS of $11.74 holds; 98% forward EPS growth is a best case not a base case; if estimates trim 15-20% (historically normal at cycle turns), stock re-rates to over 30x on revised numbers
• FCF conversion collapsed from 111% in FY24 to 67% in FY26 (44 percentage point deterioration); operating cash flow down YoY despite net income up; receivables drag of -$1.96 billion to operating cash flow
• MACD line still negative at -4.30; bullish cross from deeply negative base is counter-trend within larger bearish momentum; 50 SMA declining overhead resistance at 305; VWMA falling; session closed below open on 9.1M shares vs ~11M average
• Beta is 1.86; 52-week range 125-438; FY23 downcycle saw 14% revenue decline and 30%+ stock drawdown; cycle turns blow through 200 SMA to prior lows; stop at 269 is 12% away on high-beta name with path to stop involving break of most-watched moving average
• Consensus uniformly bullish (BofA upgrades, Zacks features, Eisman on TV, SOX up 4 sessions); Reddit silent means no retail cushion; institutional-only bid is vulnerable to rotation
• Fed hold regime with 97% probability of zero cuts is fully priced; no relief coming from rates; next macro surprise more likely hawkish than dovish; hold regime priced with continued earnings acceleration requires both to go right

→ vs aggressive: Forward P/E of 26.2x is only valid if consensus EPS of $11.74 is correct; this consensus comes from sell-side analysts in the middle of a BofA-led upgrade cycle, making it the most procyclical input in the dataset

→ vs aggressive: FCF conversion collapsed 44 percentage points from FY24 to FY26 (111% to 67%); OCF down YoY despite net income up; receivables drag of $1.96 billion is being waved away as temporary

→ vs aggressive: MACD bullish cross is from negative territory (minus 4.30); this is a counter-trend rally within bearish momentum, not a confirmed new up-leg; bounce from 265 to 307 is 14% in a 43% drawdown, not a regime change

→ vs aggressive: Risk-reward math ignores historical behavior: beta 1.86, prior downcycle saw 30%+ drawdown; 269 is not a floor when cycle turns, 200 is more likely; stop 12% away on high-beta name accelerates selling from systematic and momentum players

→ vs aggressive: Uniformly bullish sentiment (BofA, Zacks, Eisman, SOX) means no fresh capital left to chase; Reddit silence means no retail cushion to absorb institutional rotation

Maintain current position at or slightly below benchmark weight with conditional add orders (288-292 on declining volume/RSI 45-50; 330+ on confirmed breakout with volume above 12M); hard stop at 264; require Q1 FY27 results before further adjustment

• Forward P/E at 26.2x is priced for an extremely specific bullish scenario and vulnerable if estimates come down 15-20%
• MACD at minus 4.30 with cross from deeply negative territory is a counter-trend signal inside a downtrend from 438 peak
• Price closed at 307, less than 1% above 50 SMA at 305 which is declining overhead resistance; VWMA still falling
• Session closed below open on 9.1 million shares against average above 11 million
• 200 SMA at 269 is not a hard floor given 52-week low of 125, FY23 drawdown over 30%, and beta of 1.86
• Q4 FY26 record: revenue 6.72 billion, gross margin 51.7%, operating margin 37.4%, 26% revenue growth, 65% ROE, net cash position
• This is a capex trade driven by AI capex revisions and memory recovery, not a duration trade dependent on Fed cuts
• Prediction market recession probability at 8% supports continued capex
• Institutional positioning is extended (valid concern) but not a sell signal for institutional name
• MACD bullish cross with positive histogram expansion, 200 SMA held September 17, ATR coiling - constructive setup wanting to resolve higher
• No trim into current 305-315 strength as downside path is defined by 200 SMA break, not small pullback
• Setup expected to resolve in next 2-4 weeks

→ vs aggressive: Forward P/E at 26.2x is priced for extremely specific bullish scenario; prior cycles with successful 'look past TTM' strategy had different starting valuations and macro regime

→ vs aggressive: MACD bullish cross at minus 4.30 from deeply negative territory is counter-trend signal inside downtrend, not fresh momentum thrust off healthy base

→ vs aggressive: Stop at 269 with 12% distance on high-beta name at cyclical peak will get run over by systematic flow; risk math understates actual downside path

→ vs conservative: Q4 FY26 record quarter (6.72B revenue, 51.7% gross margin, 37.4% operating margin) is fresh data, not stale rearview mirror; fundamental tape has gotten stronger as stock corrected from 438 to 307

→ vs conservative: This is a capex trade, not a duration trade; Fed hold regime does not undermine capex thesis unless broader economy forces AI buildout slowdown

→ vs conservative: Absence of retail flow is structural reality, not a sell signal; Reddit silence is normal for institutional name

→ vs conservative: Institutional positioning extended is argument for not chasing aggressively, not for trimming into confirmed uptrend

→ vs conservative: Recession probability falling to 8% actually supports continued capex, not undermines it